Skip to main content

Jessica Hagen

By Jessica Hagen | 02:23 pm | June 17, 2024
Tx-LLM was fine-tuned from Google's Med-PaLM 2 and created to analyze a variety of chemical or biological entities to assist with the drug-discovery pipeline.
By Jessica Hagen | 03:54 pm | June 14, 2024
The telemedicine company's clinical president and its founder and CEO allegedly participated in a scheme to profit from providing easy access to Adderall for no valid medical purpose.
By Jessica Hagen | 03:16 pm | June 13, 2024
The company will use the funds to expand its team.
By Jessica Hagen | 12:58 pm | June 13, 2024
Naama Stauber Breckler, CEO and cofounder of Better Health, discusses the company's latest strategic funding round and how it plans to use the investment.
By Jessica Hagen | 03:33 pm | June 12, 2024
The direct-to-consumer platform will be integrated into Uwill's Urise wellness offerings.
By Jessica Hagen | 11:40 am | June 12, 2024
CALFREE uses input from optical sensors commonly found in smartwatches or commercial smartphones to collect blood pressure data.
By Jessica Hagen | 03:44 pm | June 11, 2024
The acquisition expands NeuroFlow's capabilities for behavioral health-focused measurement and engagement.
By Jessica Hagen | 01:49 pm | June 11, 2024
Movano's Evie Ring collects data on the wearer's heart rate, blood oxygen saturation levels, activity, sleep quality and menstrual cycle.
By Jessica Hagen | 08:26 am | June 06, 2024
Dr. Guido Giunti discusses patient involvement and the necessity of being forward-thinking in creating digital therapeutics.
By Jessica Hagen | 11:04 am | June 05, 2024
Cardiac and lung-disease platform Eko Health secured $41 million in Series D funding.